Enzymatic depolymerization of streptococcus pneumoniae type 8 polysaccharide.

Carbohydr Res

Analytical Research and Development, BioTherapeutics Pharmaceutical Sciences, Pfizer, Inc., 875 Chesterfield Parkway West, Chesterfield, MO, 63017, United States. Electronic address:

Published: September 2020

Although there have been decades of research on streptococcus pneumoniae, it is still among the leading cause of infectious disease in the world. As a type of capsular polysaccharide (CPS) of streptococcus pneumoniae, pneumococcal polysaccharides are essential components for colonization and virulence in mammalian hosts. This study aimed to characterize the CPS structure of type 8 streptococcus pneumoniae, which is one of the most fatal serotypes. In this work, heparinase I&III was used to successfully digest pneumococcal type 8 polysaccharide (Pn8P). We characterized the oligosaccharide generated from the enzymatic depolymerization of Pn8P by size exclusion chromatography, mass spectrometry and nuclear magnetic resonance. This is the first study to enzymatically depolymerize and characterize Pn8P.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carres.2020.108024DOI Listing

Publication Analysis

Top Keywords

streptococcus pneumoniae
16
enzymatic depolymerization
8
type polysaccharide
8
streptococcus
4
depolymerization streptococcus
4
pneumoniae
4
type
4
pneumoniae type
4
polysaccharide decades
4
decades streptococcus
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!